STEROIDS AND HEMATOPOIESIS. III. THE RESPONSE OF GRANULOCYTIC AND ERYTHROID COLONY-FORMING CELLS TO STEROIDS OF DIFFERENT CLASSES.SINGER JW; ADAMSON JW.1976; BLOOD; U.S.A.; DA. 1976; VOL. 48; NO 6; PP. 855-864; BIBL. 27 REF.Article

DETERMINATION OF FLUOXYMESTERONE, NORETHANDROLONE, PREDNISOLONE IN TABLETS BY DIFFERENTIAL PULSE POLAROGRAPHY.YADAV RN; TEARE FW.1978; J. PHARM. SCI.; U.S.A.; DA. 1978; VOL. 67; NO 3; PP. 436-438; BIBL. 25 REF.Article

Influence of fluoxymesterone on in vitro erythropoiesis effected by leucemic cellsGUI ZHI BAI; HARA, H; NAGAI, K et al.Experimental hematology. 1984, Vol 12, Num 3, pp 171-176, issn 0301-472XArticle

FLUOXYMESTERONEKIRSCHBAUM J.1978; ANAL. PROFILES DRUG SUBSTANCES; USA; DA. 1978; VOL. 7; PP. 251-275; BIBL. 71 REF.Article

PELIOSIS HEPATIS. TWELVE CASES ASSOCIATED WITH ORAL ANDROGEN THERAPY.NADELL J; KOSEK J.1977; ARCH. PATHOL. LAB. MED.; U.S.A.; DA. 1977; VOL. 101; NO 8; PP. 405-410; BIBL. 30 REF.Article

Metabolism of anabolic steroids in humans : synthesis of 6β-hydroxy metabolites of 4-chloro-1,2-dehydro-17α-methyltestosterone, fluoxymesterone, and metandienoneSCHÄNZER, W; HORNING, S; DONIKE, M et al.Steroids. 1995, Vol 60, Num 4, pp 353-366, issn 0039-128XArticle

ERYTHROPOETIN IN SERUM UND HARN VON GESUNDEN UNTER HYPOXISCHER STIMULATION UND HYPOXISCHER STIMULATION NACH ANDROGENGABE (FLUOXYMESTERON). = L'ERYTHROPOIETINE DANS LE SERUM ET L'URINE CHEZ L'HOMME SOUS STIMULATION HYPOXIQUE ET STIMULATION HYPOXIQUE APRES ANDROGENOTHERAPIE (FLUOXYMESTERONE)SCHULZ E.1977; BLUT; DTSCH.; DA. 1977; VOL. 35; NO 2; PP. 125-133; ABS. ANGL.; BIBL. 1 P.Article

APLASTIC ANEMIA WITH FETALLIKE ERYTHROPOIESIS FOLLOWING ANDROGEN THERAPY.RAGHAVENDRA RAO AN; BROWN AK; RIEDER RF et al.1978; BLOOD; USA; DA. 1978; VOL. 51; NO 4; PP. 711-719; BIBL. 1 P. 1/2Article

ANDROGEN THERAPY OF A VARICOCELE.CHECK JH; RAKOFF AE.1977; J. UROL.; U.S.A.; DA. 1977; VOL. 118; NO 3; PP. 494; BIBL. 6 REF.Article

EFFECT OF FLUOXYMESTERONE ON THE PITUITARY-GONADAL AXIS: THE ROLE OF TESTOSTERONE-ESTRADIOL-BINDING GLOBULIN.VIGERSKY RA; EASLEY RB; LORIAUX DL et al.1976; J. CLIN. ENDOCRINOL. METABOL.; U.S.A.; DA. 1976; VOL. 43; NO 1; PP. 1-9; BIBL. 23 REF.Article

SERUM-KREATININANSTIEG BEI CHRONISCH NIERENKRANKEN UNTER DEM ANDROGEN FLUOXYMESTERON. = AUGMENTATION DE LA CREATININE SERIQUE CHEZ LES MALADES AVEC AFFECTIONS RENALES CHRONIQUES SOUS CHIMIOTHERAPIE PAR L'ANDROGENE LA FLUOXYMESTERONESCHULZ E; HEINECKE G.1976; MUENCH. MED. WSCHR.; DTSCH.; DA. 1976; VOL. 118; NO 48; PP. 1559-1562; ABS. ANGL.; BIBL. 21 REF.Article

GROWTH IN TURNER'S SYNDROME: SPONTANEOUS AND FLUOXYMESTERONE STIMULATEDLENKO HL; PERHEENTUPA J; SOEDERHOLM A et al.1979; ACTA PAEDIATR. SCAND., SUPPL.; SWE; DA. 1979; NO 277; PP. 57-63; BIBL. 30 REF.Article

TREATING THE SUBFERTILE MALE PATIENT: IMPROVEMENT IN SEMEN CHARACTERISTICS AFTER LOW DOSE ANDROGEN THERAPY.URRY RL; COCKETT ATK.1976; J. UROL.; U.S.A.; DA. 1976; VOL. 116; NO 1; PP. 54-55; BIBL. 5 REF.Article

2ALPHA -3ALPHA -EPITHIO-5ALPHA -ANDROSTAN-17BETA -YL 1-METHOXYCYCLOPENTYL ETHER (10364-S), A NEW ORALLY ACTIVE ANTI-ESTROGENIC STEROID = LE 2ALPHA -3ALPHA -EPITHIO-5ALPHA -ANDROSTAN-17BETA -YL-1-METHOXY-CYCLOPENTYL-ETHER (10364-S), NOUVEAU STEROIDE ANTI-OESTROGENIQUE ACTIF PAR VOIE ORALEMIYAKE T; HORI T; KATO G et al.1974; STEROIDS; U.S.A.; DA. 1974; VOL. 23; NO 6; PP. 929-937; BIBL. 17REF.Article

THE EFFECT OF ORALLY ADMINISTERED ANDROGENS ON SPERM MOTILITYBROWN JS.1975; FERTIL AND STERIL.; U.S.A.; DA. 1975; VOL. 26; NO 4; PP. 305-308; BIBL. 7REF.Article

Androgen therapy in the treatment of refractory epithelial ovarian cancerKAVANAGH, J. J; WHARTON, J. T; ROBERTS, W. S et al.Cancer treatment reports. 1987, Vol 71, Num 5, pp 537-538, issn 0361-5960Article

Androgen priming and response to chemotherapy in advanced prostatic cancerMANNI, A; SANTEN, R. J; WETTLAUFER, J et al.The Journal of urology. 1986, Vol 136, Num 6, pp 1242-1246, issn 0022-5347Article

RADIOIMMUNOASSAY FOR FLUOXYMESTERONE (HALOTESTIN) = DOSAGE RADIOIMMUNOLOGIQUE DE LA FLUOXYMESTERONE (HALOTESTINE)COLBURN WA.1975; STEROIDS; U.S.A.; DA. 1975; VOL. 25; NO 1; PP. 43-52; BIBL. 15 REF.Article

ANDROGEN PRIMING AND CYTOTOXIC CHEMOTHERAPY IN ADVANCED PROSTATIC CANCERSUAREZ AJ; LAMM DL; RADWIN HM et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 8; NO 3; PP. 261-265; BIBL. 21 REF.Article

Response to tamoxifen and fluoxymesterone in a group of breast cancer patients with disease recurrence after cessation of adjuvant tamoxifenFORNANDER, T; RUTQVIST, L. E; GLAS, U et al.Cancer treatment reports. 1987, Vol 71, Num 7-8, pp 685-688, issn 0361-5960Article

Testing for fluoxymesterone (halotestin ®) administration to man : identification of urinary metabolites by gas chromatography-mass spectrometryKAMMERER, R. C; MERDINK, J. L; JAGELS, M et al.Journal of steroid biochemistry. 1990, Vol 36, Num 6, pp 659-666, issn 0022-4731, 8 p.Article

Mass spectrometric identification and characterization of new fluoxymesterone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometryJIANGHAI LU; GENYE HE; XIAOBING WANG et al.Steroids. 2012, Vol 77, Num 8-9, pp 871-877, issn 0039-128X, 7 p.Article

Pulmonary peliosisLIE, J. T.Archives of pathology & laboratory medicine (1976). 1985, Vol 109, Num 9, pp 878-879, issn 0363-0153Article

EFFECTS OF THE SYNTHETIC ANDROGEN FLUOXYMESTERONE ON TRIGLYCERIDE SECRETION RATES IN THE RAT. = EFFETS DE L'ANDROGENE SYNTHETIQUE FLUOXYMESTERONE SUR LES TAUX DE SECRETION DES TRIGLYCERIDES CHEZ LE RATBAGDADE JD; LIVINGSTON R; YEE E et al.1975; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1975; VOL. 149; NO 2; PP. 452-454; BIBL. 13 REF.Article

ZUM VERHALTEN DES ERYTHROPOETINS BEI AREGENERATORISCHEN BLUTBILDUNGSSTOERUNGEN UNTER THERAPIE MIT ANABOLEN STEROIDEN = TAUX D'ERYTHROPOIETINE DANS LES MALADIES HEMATOLOGIQUES DEGENERATIVES TRAITEES PAR DES STEROIDES ANABOLISANTSNEUMANN E; HONETZ N; WURM B et al.1974; BLUT; DTSCH.; DA. 1974; VOL. 29; NO 6; PP. 373-381; ABS. ANGL.; BIBL. 25REF.Article